Abscience Alzheimer Study: Masitinib Shows Promise (EPA:AB)
Masitinib’s Promise: Reshaping the Future of Alzheimer’s Treatment The landscape of Alzheimer’s disease treatment is undergoing a significant transformation. Recent research, highlighted by a peer-reviewed study from the Guangdong Pharmaceutical University and Sun Yat-sen University, spotlights masitinib’s potential. This drug, initially designed for other conditions, is showing remarkable promise in tackling the complexities of sporadic … Read more